Kura Oncology (KURA) Capital Expenditures (2014 - 2026)
Kura Oncology (KURA) reported Capital Expenditures of $128000.0 for Q1 2026, down 56.16% year-over-year from $292000.0 in Q1 2025, and down 97.22% on a QoQ basis from $4.6 million in Q4 2025.
Kura Oncology (KURA) has 9 years of Capital Expenditures data on file, last reported at $128000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 56.16% year-over-year to $128000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 852.06% YoY) and the FY2025 annual result came in at $6.6 million, up 1306.36% from the prior year.
- Capital Expenditures retreated to $128000.0 in Q1 2026 per KURA's latest filing, from $4.6 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.6 million in Q4 2025 and bottomed at $12000.0 in Q4 2022.
- The 5-year median for Capital Expenditures is $112000.0 (2023), against an average of $502000.0.
- The widest annual swing landed in 2023, when Capital Expenditures tumbled 94.75%; it then jumped 9012.5% in 2025.
- Tracing KURA's Capital Expenditures over 5 years: stood at $12000.0 in 2022, then jumped by 33.33% to $16000.0 in 2023, then surged by 2225.0% to $372000.0 in 2024, then surged by 1139.52% to $4.6 million in 2025, then sank by 97.22% to $128000.0 in 2026.
- Per Business Quant, the three latest KURA Capital Expenditures figures stand at $128000.0 (Q1 2026), $4.6 million (Q4 2025), and $277000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128,000.00 |
| Mar 31, 2026 | 128,000.00 |
| Dec 31, 2025 | 4.61 Mn |
| Dec 31, 2025 | 4.61 Mn |
| Sep 30, 2025 | 277,000.00 |
| Sep 30, 2025 | 277,000.00 |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 292,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 381,000.00 |
| Sep 30, 2022 | 381,000.00 |
| Jun 30, 2022 | 184,000.00 |
| Jun 30, 2022 | 184,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Dec 31, 2021 | 102,000.00 |
| Dec 31, 2021 | 102,000.00 |
| Sep 30, 2021 | 723,000.00 |
| Sep 30, 2021 | 723,000.00 |
| Jun 30, 2021 | 291,000.00 |
| Jun 30, 2021 | 291,000.00 |
| Mar 31, 2021 | 31,000.00 |
| Mar 31, 2021 | 31,000.00 |
| Dec 31, 2020 | 275,000.00 |
| Dec 31, 2020 | 275,000.00 |
| Sep 30, 2020 | 665,000.00 |
| Sep 30, 2020 | 665,000.00 |
| Jun 30, 2020 | 720,000.00 |
| Jun 30, 2020 | 720,000.00 |
| Mar 31, 2020 | 511,000.00 |
| Mar 31, 2020 | 511,000.00 |
| Dec 31, 2015 | 15,000.00 |
| Dec 31, 2015 | 15,000.00 |
| Sep 30, 2015 | 22,000.00 |
| Sep 30, 2015 | 22,000.00 |
| Jun 30, 2015 | 17,000.00 |
| Jun 30, 2015 | 17,000.00 |
| Mar 31, 2015 | 10,000.00 |
| Mar 31, 2015 | 10,000.00 |
| Dec 31, 2014 | 28,000.00 |
| Dec 31, 2014 | 28,000.00 |
| Sep 30, 2014 | 11,000.00 |
| Sep 30, 2014 | 11,000.00 |